{
    "URL": "https://doi.org/10.1371/journal.pntd.0009354",
    "Published": "April 20, 2021",
    "Subject_Areas": [
        "Benzimidazoles",
        "Onchocerciasis",
        "Drug administration",
        "Adverse reactions",
        "Loa loa",
        "Drug safety",
        "Neurological drug therapy",
        "Strongyloidiasis"
    ],
    "Authors": {
        "J\u00e9r\u00e9my T. Campillo": [
            "TransVIHMI, Universit\u00e9 Montpellier, Institut de Recherche pour le D\u00e9veloppement (IRD), INSERM, Montpellier, France",
            "Department of medical pharmacology and toxicology, CHU Montpellier, Montpellier, France"
        ],
        "Michel Boussinesq": [
            "TransVIHMI, Universit\u00e9 Montpellier, Institut de Recherche pour le D\u00e9veloppement (IRD), INSERM, Montpellier, France"
        ],
        "S\u00e9bastien Bertout": [
            "TransVIHMI, Universit\u00e9 Montpellier, Institut de Recherche pour le D\u00e9veloppement (IRD), INSERM, Montpellier, France",
            "Laboratoire de Parasitologie et Mycologie M\u00e9dicale, Universit\u00e9 de Montpellier, Montpellier, France"
        ],
        "Jean-Luc Faillie": [
            "Department of medical pharmacology and toxicology, CHU Montpellier, Montpellier, France",
            "EA 2415, IDESP, University of Montpellier, Montpellier, France"
        ],
        "C\u00e9dric B. Chesnais": [
            "TransVIHMI, Universit\u00e9 Montpellier, Institut de Recherche pour le D\u00e9veloppement (IRD), INSERM, Montpellier, France"
        ]
    }
}